Financials Idorsia Ltd

Equities

IDIA

CH0363463438

Biotechnology & Medical Research

Market Closed - Swiss Exchange 11:31:13 2024-05-23 am EDT 5-day change 1st Jan Change
2.208 CHF -2.13% Intraday chart for Idorsia Ltd -5.88% +4.45%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 3,929 4,248 3,298 2,383 376.8 395.2 - -
Enterprise Value (EV) 1 3,769 3,828 4,290 3,367 376.8 1,579 1,727 2,343
P/E ratio -7.96 x -8.21 x -4.94 x -2.87 x -1.27 x -1.48 x -2.25 x -4.13 x
Yield - - - - - - - -
Capitalization / Revenue 164 x 59 x 94.2 x 24.6 x 2.48 x 2.92 x 1.52 x 0.87 x
EV / Revenue 157 x 53.2 x 123 x 34.7 x 2.48 x 11.7 x 6.62 x 5.14 x
EV / EBITDA -8.16 x -9.79 x -7.21 x -4.57 x -0.78 x -4.25 x -6.55 x -43.3 x
EV / FCF -7.02 x -10.2 x -6.87 x -3.84 x - -2.88 x -4.56 x -
FCF Yield -14.2% -9.77% -14.5% -26% - -34.8% -21.9% -
Price to Book 22.8 x 6.24 x 31.7 x -3.61 x - -0.49 x -0.41 x -0.22 x
Nbr of stocks (in thousands) 131,235 166,466 176,955 177,543 178,261 178,967 - -
Reference price 2 29.94 25.52 18.64 13.42 2.114 2.208 2.208 2.208
Announcement Date 2/6/20 2/4/21 2/8/22 2/7/23 5/21/24 - - -
1CHF in Million2CHF
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 24 72 35 97 152 135.3 260.7 455.5
EBITDA 1 -462 -391 -595 -737.2 -482 -371.3 -263.4 -54.15
EBIT 1 -482 -411 -613 -757 -501 -388.9 -331.4 -141.9
Operating Margin -2,008.33% -570.83% -1,751.43% -780.41% -329.61% -287.38% -127.12% -31.15%
Earnings before Tax (EBT) 1 -485 -449 -634.8 -820.1 -294 -406.7 -358.1 -166.6
Net income 1 -494 -445 -635 -828 -298 -406.7 -348.9 -160.8
Net margin -2,058.33% -618.06% -1,814.29% -853.61% -196.05% -300.51% -133.84% -35.3%
EPS 2 -3.760 -3.110 -3.770 -4.670 -1.670 -1.490 -0.9818 -0.5349
Free Cash Flow 1 -536.8 -373.9 -624 -875.7 - -548.9 -378.8 -
FCF margin -2,236.86% -519.35% -1,782.86% -902.81% - -405.56% -145.27% -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 - - - - - - - -
Announcement Date 2/6/20 2/4/21 2/8/22 2/7/23 5/21/24 - - -
1CHF in Million2CHF
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 S1 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 13 5 5 17 21 54 21 30 80 22 10.06 112.3 13.35 21.09 52.45
EBITDA - -224 -187.8 -207 -189 -174.3 -193 -173 -37 - - - - - -
EBIT 1 -234 -228 -193 -212 -193 -180 -198 -177 231 -115 30.94 -16.49 -121.5 -124.1 -80.4
Operating Margin -1,800% -4,560% -3,860% -1,247.06% -919.05% -333.33% -942.86% -590% 288.75% -522.73% 307.63% -14.68% -909.78% -588.48% -153.29%
Earnings before Tax (EBT) - -253 -196 -222 -216 -190.3 -212 -192 225 -116 - - - - -
Net income -223 -252 -198 -222 -216 -193 -212 -193 224 -117 - - - - -
Net margin -1,715.38% -5,040% -3,960% -1,305.88% -1,028.57% -357.41% -1,009.52% -643.33% 280% -531.82% - - - - -
EPS 2 -1.340 -1.460 -1.120 -1.250 -1.220 -1.090 -1.190 -1.080 0.9600 -0.6500 0.1300 -0.1000 -0.4100 -0.3000 -0.2000
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 7/27/21 2/8/22 4/26/22 7/26/22 10/25/22 2/7/23 4/25/23 7/25/23 10/24/23 5/21/24 5/21/24 - - - -
1CHF in Million2CHF
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - 991 984 - 1,184 1,331 1,948
Net Cash position 1 160 421 - - - - - -
Leverage (Debt/EBITDA) - - -1.666 x -1.335 x - -3.188 x -5.055 x -35.97 x
Free Cash Flow 1 -537 -374 -624 -876 - -549 -379 -
ROE (net income / shareholders' equity) -118% -103% -167% - - - - -
ROA (Net income/ Total Assets) - -32.1% -39.4% -65.5% - -58.4% -34.5% -19.4%
Assets 1 - 1,385 1,611 1,264 - 696.3 1,010 830.8
Book Value Per Share 2 1.310 4.090 0.5900 -3.720 - -4.540 -5.400 -9.950
Cash Flow per Share 2 -3.520 -2.550 -3.500 -4.840 - -3.170 -1.350 -0.4700
Capex 1 18.8 9.27 25.5 16.6 - 15.9 22.8 64.5
Capex / Sales 78.34% 12.87% 72.93% 17.13% - 11.75% 8.73% 14.16%
Announcement Date 2/6/20 2/4/21 2/8/22 2/7/23 5/21/24 - - -
1CHF in Million2CHF
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
8
Last Close Price
2.208 CHF
Average target price
1.692 CHF
Spread / Average Target
-23.35%
Consensus
  1. Stock Market
  2. Equities
  3. IDIA Stock
  4. Financials Idorsia Ltd